Heck Capital Advisors’s Labcorp LH Stock Holding History

Heck Capital Advisors’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-193	Closed	-$44.3K	–	545
2024 Q4	$44.3K	Buy	+193	New	+$44.3K	﹤0.01%	380

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Heck Capital Advisors's LH Position: Q1 2025 in Review

Heck Capital Advisors sold out of Labcorp (LH) in Q1 2025, closing a stake of 193 shares — an estimated $44.3K sold.

Heck Capital Advisors first reported a position in LH in Q4 2024 and held it in 1 quarter. The position peaked at $44.3K in Q4 2024. 976 funds tracked by Wall St. Rank hold LH as of Q1 2025.

Heck Capital Advisors reported no remaining Labcorp position as of Q1 2025 after selling out during the quarter.
Heck Capital Advisors sold 193 Labcorp shares in Q1 2025, an estimated $44.3K.
Heck Capital Advisors first reported a position in Labcorp in Q4 2024 and held it in 1 quarter.
Heck Capital Advisors's Labcorp position peaked at $44.3K in Q4 2024.
976 funds tracked by Wall St. Rank held Labcorp as of Q1 2025.

Based on Heck Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.